FDA panel weighs access to 7 unapproved injectable peptides
What's next: Advisers are set to vote after FDA staff urged keeping compounding limits because human evidence is thin.
What's next: Advisers are set to vote after FDA staff urged keeping compounding limits because human evidence is thin.
What's new: officials say recalls are in place, but the FDA still lacks a lab-confirmed positive sample from the suspected product.
What's new: Service members with low levels can get voluntary hormone therapy as the policy takes effect immediately.
What's at stake: If confirmed, Schwartz would become Trump's third CDC pick and take over an agency without a permanent chief for most of his second term.
What's new: Prosecutors allege Andrea Renee Shaw suffocated the children, undercutting a claim amplified by Children’s Health Defense.
What's next: The FDA is expected to decide by Aug. 5 on what could become the first mRNA-based seasonal flu vaccine.